article

Genomics / Sequencing supplement 2011

In this Genomics / Sequencing supplement: NGS powers up drug discovery and healthcare; Impact of novel sequencing technology on transcriptome analysis; Making sense of nonesense (and missense): Bringing the results of recent genetic studies into the drug discovery laboratory…

Genomics supplement 2011
  • NGS powers up drug discovery and healthcare (Bhupinder Bhullar, Novartis Pharma AG)
  • Impact of novel sequencing technology on transcriptome analysis (Wei Chen, Max Delbrück Center for Mollecular Medicine Berlin-Buch)
  • Making sense of nonsense (and missense): Bringing the results of recent genetic studies into the drug discovery laboratory (Stephen A. Haney, Biological Profiling, Applied Quantitative Genotherapeutics, Pfizer Biotechnologies Unit)
  • Show previews (Next Generation Sequencing Congress 2011, MipTec 2011)

This Genomics / Sequencing supplement is restricted - login or subscribe free to access

European Pharmaceutical Review Issue 3 2022Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here